Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

InspireMD (NSPR) Profit After Tax (2016 - 2025)

InspireMD filings provide 16 years of Profit After Tax readings, the most recent being -$11.8 million for Q4 2025.

  • On a quarterly basis, Profit After Tax fell 28.2% to -$11.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$48.8 million, a 52.43% decrease, with the full-year FY2025 number at -$48.8 million, down 52.43% from a year prior.
  • Profit After Tax hit -$11.8 million in Q4 2025 for InspireMD, up from -$12.7 million in the prior quarter.
  • In the past five years, Profit After Tax ranged from a high of -$3.2 million in Q1 2021 to a low of -$13.2 million in Q2 2025.
  • Median Profit After Tax over the past 5 years was -$5.1 million (2023), compared with a mean of -$6.7 million.
  • Biggest five-year swings in Profit After Tax: plummeted 82.31% in 2021 and later rose 5.02% in 2023.
  • InspireMD's Profit After Tax stood at -$4.1 million in 2021, then fell by 18.26% to -$4.8 million in 2022, then fell by 11.56% to -$5.4 million in 2023, then tumbled by 69.73% to -$9.2 million in 2024, then decreased by 28.2% to -$11.8 million in 2025.
  • The last three reported values for Profit After Tax were -$11.8 million (Q4 2025), -$12.7 million (Q3 2025), and -$13.2 million (Q2 2025) per Business Quant data.